Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: randomised controlled trial.

Boyer L, Lançon C, Baumstarck K, Parola N, Berbis J, Auquier P.

Br J Psychiatry. 2013 Jun;202:447-53. doi: 10.1192/bjp.bp.112.123463. Epub 2013 May 9.

2.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

3.

[Relationship between insight and self-reported quality of life among shizophrenic patients].

Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C.

Encephale. 2011 Jun;37(3):162-71. doi: 10.1016/j.encep.2010.08.011. Epub 2010 Oct 20. French.

PMID:
21703431
4.
5.

Hospital and community-based care for patients with chronic schizophrenia in Hong Kong--quality of life and its correlates.

Chan GW, Ungvari GS, Shek DT, Leung Dagger JJ.

Soc Psychiatry Psychiatr Epidemiol. 2003 Apr;38(4):196-203.

PMID:
12664230
6.

Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life.

Bechdolf A, Knost B, Nelson B, Schneider N, Veith V, Yung AR, Pukrop R.

Aust N Z J Psychiatry. 2010 Feb;44(2):144-50. doi: 10.3109/00048670903393571.

PMID:
20113303
7.

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE).

Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn D, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team.

Health Technol Assess. 2012;16(8):iii-iv, 1-76. doi: 10.3310/hta16080.

9.

A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.

Gowers SG, Clark AF, Roberts C, Byford S, Barrett B, Griffiths A, Edwards V, Bryan C, Smethurst N, Rowlands L, Roots P.

Health Technol Assess. 2010 Mar;14(15):1-98. doi: 10.3310/hta14150.

10.

Quality of life in first-admitted schizophrenia patients: a follow-up study.

Priebe S, Roeder-Wanner UU, Kaiser W.

Psychol Med. 2000 Jan;30(1):225-30.

PMID:
10722193
11.

Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis.

Lai PS, Chua SS, Chan SP.

Int J Clin Pharm. 2013 Aug;35(4):629-37. doi: 10.1007/s11096-013-9784-x. Epub 2013 May 16.

PMID:
23677816
12.

Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.

McNaughton-Collins M, Walker-Corkery E, Barry MJ.

J Natl Cancer Inst Monogr. 2004;(33):78-101. Review.

PMID:
15504921
13.

Measuring quality of life in patients with schizophrenia:an overview.

Boyer L, Baumstarck K, Boucekine M, Blanc J, Lançon C, Auquier P.

Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):343-9. doi: 10.1586/erp.13.15. Review.

PMID:
23763531
14.
15.

A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.

Ishak WW, Balayan K, Bresee C, Greenberg JM, Fakhry H, Christensen S, Rapaport MH.

Qual Life Res. 2013 Apr;22(3):585-96. doi: 10.1007/s11136-012-0187-6. Epub 2012 Apr 29.

PMID:
22544416
16.
17.

Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial.

Crawford MJ, Killaspy H, Barnes TR, Barrett B, Byford S, Clayton K, Dinsmore J, Floyd S, Hoadley A, Johnson T, Kalaitzaki E, King M, Leurent B, Maratos A, O'Neill FA, Osborn DP, Patterson S, Soteriou T, Tyrer P, Waller D; MATISSE project team.

BMJ. 2012 Feb 28;344:e846. doi: 10.1136/bmj.e846.

18.

A longitudinal study of patient- and observer-rated quality of life in schizophrenia.

Fitzgerald PB, de Castella AR, Filia K, Collins J, Brewer K, Williams CL, Davey P, Kulkarni J.

Psychiatry Res. 2003 Jul 15;119(1-2):55-62.

PMID:
12860360
19.

Assessment of quality of life during chemotherapy.

Gunnars B, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):175-84. Review.

PMID:
11441930
20.

The quality of life of patients suffering from schizophrenia--a comparison with healthy controls.

Sidlova M, Prasko J, Jelenova D, Kovacsova A, Latalova K, Sigmundova Z, Vrbova K.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Jun;155(2):173-80.

Supplemental Content

Support Center